Navigation Links
‘Grand Challenge’ targeting prostate lesion diagnostic imaging is launched
Date:11/24/2016

Training data sets were released this week in a “Grand Challenge” on quantitative image analysis methods for diagnosing clinically significant prostate lesions. Participants in the PROSTATEx Challenge being conducted by SPIE, the international society for optics and photonics, and supported by the American Association of Physicists in Medicine (AAPM) and the National Cancer Institute (NCI) will compare results during SPIE Medical Imaging 2017 in Orlando, Florida, in February.

“The PROSTATEx Challenge will provide a unique opportunity for participants to compare their algorithms with those of others from academia, industry, and government in a structured, direct way using the same data sets,” said Samuel Armato (University of Chicago), one of the challenge organizers.

Training set cases with truth were released 22 November, and test set cases without truth will be released 12 December.

Participants’ output from the test set classification is due 15 January, and challenge results will be released to participants on 20 January.

The two top-performing PROSTATEx Challenge participants will receive waivers of the conference registration fee in order to present their methods during a special session during the meeting, and will be recognized during the conference plenary session.

Challenge participants who submit test set classification results by 15 January will be invited to present posters and demonstrate their algorithms in the live demonstration CAD Workshop during the meeting.

Participants are encouraged to submit their work to the CAD conference proceedings volume as well as for peer review to the SPIE Journal of Medical Imaging. SPIE 2016 Vice President and long-time conference organizer Maryellen Giger (University of Chicago) is editor-in-chief.

The database for this challenge will contain a total of approximately 350 MRI cases consisting of four DICOM-formatted MRI datasets, each from a single examination on a particular patient. Approximately 60% of the cases will serve as the training set, and the remainder will serve as the test set, with each case consisting of four sets of MRI scan data.

A discussion of lessons learned from the 2015 LUNGx Challenge, also sponsored by SPIE, AAPM, and NCI, appears in a guest editorial by Armato and other organizers in the SPIE Digital Library.

SPIE Medical Imaging runs 11 through 16 February. In addition to the PROSTATEx Challenge, other highlights are the Ultrasound Computer Tomography data challenge; a plenary talk by Google Senior Research Scientist Greg Corrado on applying deep learning to medical imaging; and an applications track in Precision Medicine.

About SPIE

SPIE is the international society for optics and photonics, an educational not-for-profit organization founded in 1955 to advance light-based science, engineering, and technology. The Society serves nearly 264,000 constituents from approximately 166 countries, offering conferences and their published proceedings, continuing education, books, journals, and the SPIE Digital Library. In 2015, SPIE provided more than $5.2 million in support of education and outreach programs. http://www.spie.org

Read the full story at http://www.prweb.com/releases/2016/11/prweb13876432.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related biology technology :

1. RG-125(AZD4076), a microRNA Therapeutic Targeting microRNA-103/107 Being Developed for the Treatment of NASH in Patients with Type 2 Diabetes/Pre-Diabetes, Enters Phase I Clinical Development
2. Targeting Nerve Endings To Curb Allergic Asthma
3. Diasome Pharmaceuticals, Inc. Announces Notice of Allowance from US PTO for Liver Targeting System for Insulin
4. CapRock Research Initiates Analyst Coverage of Actinium Pharmaceuticals: Targeting a Killer Issued by Small Cap IR
5. PositiveID Analyst Coverage Continued by Small Cap IR: BioThreat Detection Contender Targeting Ebola with Leading Edge Technology
6. GenSperas CEO Shares Insight on Unique Properties and Targeting of Lead Drug G-202, Based on the Thapsigargin Toxin
7. RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders
8. Study: Risk of Acquiring Genital Warts in the Mouth from Sex is 50%; polyDNA Recommends Targeting Latent HPV with Gene-Eden-VIR
9. Singapore Focus Chemistry Launches New Website, Www.FocusChemistry.Com, Targeting A Level Chemistry Students
10. QIAGEN Announces Partnership With Clovis Oncology to Co-develop Companion Diagnostic Targeting Drug-Resistant EGFR Mutations
11. GUARDaHEART to Host Exclusive Event focused on Targeting Heart Disease in Celebration of the World Heart Day Mission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2019)... ... July 30, 2019 , ... The summer season has been ... Not only has the company already hosted many of its signature cooking classes ... its guests. , With Lajollacooks4u’s Private Cooking Parties, guests prepare and enjoy a ...
(Date:7/19/2019)... ... July 18, 2019 , ... ... Everest,” will be joining forces with California-based charity Coalition Duchenne for its 9th ... Coalition Duchenne raises awareness and funding for Duchenne muscular dystrophy and was founded ...
(Date:7/11/2019)... LAS VEGAS (PRWEB) , ... July 11, 2019 , ... ... 2019, R3 provided complimentary regenerative therapies to eight military Veterans under the R3 Heroes ... procedures being complimentary. , The R3 Heroes Program allow anyone to nominate a military ...
(Date:6/26/2019)... ... June 26, 2019 , ... Alice Branton today released ... improving physicochemical properties of Magnesium Gluconate, which can prove to be beneficial for treating ... of characteristic differentiation peak, change in crystallite size , Over 142% increase ...
Breaking Biology Technology:
(Date:8/14/2019)... ... August 14, 2019 , ... Join Jonathan Riek, PhD, ... on Tuesday, September 10, 2019 at 1pm EDT to learn about two common ... management. , NAFLD is the most common diffuse liver disease, with a worldwide ...
(Date:8/14/2019)... ... August 14, 2019 , ... Gateway Genomics , a ... announces inclusion in the 38th annual Inc. 500|5000 list of fastest growing ... qualify, companies must have been founded and generating revenue by March 31, 2015. Ranking ...
(Date:8/14/2019)... (PRWEB) , ... August 13, 2019 , ... Dr. Julie Reck of Veterinary Medical ... to her patients. Her first stem cell patient, her own geriatric Australian Shepherd, Simon, ... to Dr. Reck, Simon wanted to play but his body was weak, and he struggled ...
Breaking Biology News(10 mins):